Survey respondents each reported an average of five pelvic health issues, including painful periods, pelvic floor dysfunction, fibroids and regular yeast infections.
The Japanese chemical company said Thursday it would stop marketing the Medicago-produced Covifenz vaccine, which is plant-based and was approved by Health Canada one year ago for adults aged 18 to 64.